Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Cancer Causes & Control : CCC|June 20, 2018
Regular aspirin use and gene expression profiles in prostate cancer patientsKonrad H Stopsack, Ericka M Ebot, Mary K Downer, et al.Cancer Epidemiology|September 26, 2021
A prospective study of inflammatory biomarkers and growth factors and risk of glioma in the UK BiobankDavid J Cote, Jordan H Creed, Claudine M Samanic, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 24, 2019
Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific RiskJordan H Creed, Anders E Berglund, Robert J Rounbehler, et al.Journal of Cancer Research and Clinical Oncology|January 15, 2019
Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignmentChristian Daniel Fankhauser, Travis A Gerke, Lisa Roth, et al.The Prostate|April 29, 2026
A Gene Expression Tumor Signature Optimizing Partial Area-Under-the-Curve (pAUC) to Improve Specificity for Indolent Prostate CancerTravis A Gerke, Svitlana Tyekucheva, Konrad H Stopsack, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 12, 2020
Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up StudySaud Khan, Joshua Caldwell, Kathryn M Wilson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2020
Multiplex Immunofluorescence in Formalin-Fixed Paraffin-Embedded Tumor Tissue to Identify Single-Cell-Level PI3K Pathway ActivationKonrad H Stopsack, Ying Huang, Svitlana Tyekucheva, et al.The Prostate|October 16, 2015
Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUCTravis A Gerke, Neil E Martin, Zhihu Ding, et al.Cancer Epidemiology|May 20, 2018
Toenail selenium, genetic variation in selenoenzymes and risk and outcome in gliomaNoah C Peeri, Jordan H Creed, Gabriella M Anic, et al.Scientific Reports|July 28, 2019
Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of gliomaJordan H Creed, Noah C Peeri, Gabriella M Anic, et al.Pageof 4